CD4 and atherosclerosis: Here, we reviewed the mechanisms of Th17 cell- and Treg-mediated atherosclerosis in existing CD4+ T cell subpopulations, thereby providing targets for atherosclerosis treatment and a feasible direction for research on the inhibition of atherosclerosis progression through immunomodulation.